[1]CurrentPatentAssignee:EVOTECAG-WO2007/59905,2007,A2Locationinpatent:Page/Pagecolumn44
[2]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2006/136402,2006,A1Locationinpatent:Page/Pagecolumn67
[1]Phosphorus,SulfurandSiliconandtheRelatedElements,2009,vol.184,p.3241-3257
[1]EuropeanJournalofMedicinalChemistry,2016,vol.123,p.31-47
[2]Patent:CN105218557,2016,A.Locationinpatent:Paragraph0217;0218;0219
[3]EuropeanJournalofMedicinalChemistry,2016,vol.115,p.148-160
[4]SyntheticCommunications,2011,vol.41,p.2835-2851
[5]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.496-500
[6]ChemicalBiologyandDrugDesign,2017,vol.90,p.1115-1121
[7]EuropeanJournalofMedicinalChemistry,2019,vol.168,p.474-490
[1]Patent:WO2012/97013,2012,A1.Locationinpatent:Page/Pagecolumn198
[1]CurrentPatentAssignee:HUBEIUNIVERSITYFORNATIONALITIES-CN106243124,2016,ALocationinpatent:Paragraph0114-0118
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101